Targeting the Beta-Cell in Diabetes Therapeutics

Targeting the Beta-Cell in Diabetes Therapeutics

Record date: Sep 12, 2012

Michelle Kimple, an assistant professor in the Department of Medicine at UW-Madison, discusses the role of the insulin-producing beta-cell in the pathophysiology of diabetes, particularly type 2 (obesity-related) diabetes, and the mechanisms of action of established and novel diabetes therapeutics that act on the beta-cell.

UP Campus: 

Up Lecture Series: 

UP Subjects: